Kornitzer Capital Management Inc. sells CarGurus, Inc. (NASDAQ:CARG) stock.
According to the most recent filing that the company has made with the SEC, Kornitzer Capital Management Inc. decreased its ...
Tag: CARG, Analyst Rating
Analysts have assigned CarGurus, Inc. (NASDAQ:CARG) a consensus rating of “Moderate Buy.”
According to Bloomberg Ratings, the stock has received an average recommendation of "Moderate Buy" from the fourteen rating agencies currently ...
According to the most recent Securities and Exchange Commission filing, Raymond James Trust N.A. increased its stake in CarGurus, Inc. (NASDAQ:CARG) by 38.2% in the third quarter. After purchasing an additional 6,298 shares during the quarter, the fund now owns 22,773 shares of the company’s stock. Raymond James Trust N.A. held $323,000 in CarGurus at the end of the most recent reporting period.
Other institutional investors have been buying and selling shares of CARG recently, indicating that they are active in the market. ...
CarGurus, Inc. (NASDAQ:CARG) short interest rises by 26.2%.
Significantly more short positions were held in CarGurus, Inc. (NASDAQ: CARG) during November. As of November 15th, the total number ...
Jefferies Financial Group predicts CarGurus, Inc. will earn $0.10 per share in the first quarter of 2023.
Check Point Software Technologies Ltd. trades on the NASDAQ under the ticker symbol CHKP and develops security software. In a ...
CarGurus (NASDAQ:CARG) drops to a new 12-month low following an analyst downgrade.
CarGurus, Inc. (NASDAQ: CARG) stock dropped to a new 52-week low on Wednesday after BTIG Research cut its price target ...
Analysts unanimously recommend CarGurus, Inc. (NASDAQ:CARG) as a “Moderate Buy.”
According to Bloomberg.com, the twelve research firms currently keeping an eye on Exelixis, Inc. (NASDAQ: EXEL) have collectively assigned the ...
Short Interest Rises By 10.5% in CarGurus, Inc. (NASDAQ:CARG)
In September, short interest in CarGurus, Inc. (NASDAQ: CARG) grew noticeably. On August 31, there were 6,930,000 shares short; as ...
Analysts have assigned a consensus rating of “Moderate Buy” to Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).
According to Bloomberg.com, the fourteen research firms that follow Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have provided the company with a ...
CarGurus (NASDAQ:CARG) Issues Earnings Guidance for the Third Quarter of 2022
On Monday morning, CarGurus (NASDAQ: CARG) updated its earnings prediction for the third quarter of 2022 and disclosed it to ...
